Home › Stocks › ADVM

Adverum Biotechnologies, Inc. (ADVM): insider buying, hedge funds & Congress trades

Adverum Biotechnologies, Inc. (ADVM): 9 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Dec 8, 2025Soparkar Peter
Officer
50,000$4.22$211.0Kno history
Dec 8, 2025Fischer Laurent
Director, Officer
128,699$4.30$553.9Kno history
Apr 28, 2025Leonard Braden Michael
TenPercentOwner
37,000$5.11$189.0Kno history
Apr 28, 2025Leonard Braden Michael
TenPercentOwner
37,000$5.11$189.0Kno history
Apr 24, 2025Leonard Braden Michael
TenPercentOwner
350,000$3.00$1.0Mno history
Apr 2, 2025Leonard Braden Michael
TenPercentOwner
34,775$4.23$147.1Kno history
Mar 27, 2025Leonard Braden Michael
TenPercentOwner
20,407$5.04$102.9Kno history
Mar 20, 2025Leonard Braden Michael
TenPercentOwner
117,941$4.98$587.7Kno history
Feb 28, 2025Leonard Braden Michael
TenPercentOwner
336,756$4.28$1.4Mno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for ADVM

Free account. Know when insiders, famous funds or Congress trade it.

Start free